Company / Total Debt
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Total Debt History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$896.7M
FY2022
5-year range
$896.1M / $896.7M
FY2018-FY2022
Trend
+0.1%
vs FY2021
Sector context
#57 of 100
Health Care
What the data says
At $897M, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s total debt ranks #44 of 100 in the Health Care sector. Total Debt has increased for 4 consecutive years, from $14M in FY2017 to $897M in FY2022.
Based on SEC 10-K filings.
$897M in FY2022 with a 5-year CAGR of +131.0%.
Increased from $16M to $897M over the past 3 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +283.7%
- 5-Year CAGR
- +131.0%
- 10-Year CAGR
- -
Sector benchmark
#44 of 100 in Health CareTop 43% of 100This company $896.7M Sector average $4.6B
▼
-80.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +131.0%, indicating consistent growth.
- In FY2022, total debt increased 0.1% year-over-year.
- Ranks #57 out of 100 companies in the Health Care sector.
- Lowest total debt in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $896.7M | +0.1% |
| FY2021 | $896.1M | - |
| FY2020 | - | - |
| FY2019 | $15.9M | +8.3% |
| FY2018 | $14.7M | +7.5% |
| FY2017 | $13.6M | -15.3% |
| FY2016 | $16.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026